FDA NDC Directory · JSON-LD · Markdown

Oxaprozin

NDC 70512-787 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerSOLA Pharmaceuticals, LLC
Marketing categoryNew Drug Application (innovator) · App NDA217927
Dosage form / routeCAPSULE · ORAL
Active ingredientsOXAPROZIN (300 mg/1)
Marketing started20251203
Package count1

External sources

Source: openFDA. Public-domain (CC0).